Default company panoramic image
Logo

Genogen

Regenerating Skin for Life. Regenerative Medicine company with patented technology activating skin stem cells for new skin repair solutions

  • Stage Concept Only
  • Industry Biotechnology
  • Location Mountain View, CA, USA
  • Currency USD

Company Summary

Genogen offers the opportunity for rapid entry into the burn, scar, skin repair, and anti-aging market. Product development is largely complete and studies in humans are underway. Product is a novel combination of two FDA approved drugs, minimizing safety concerns and the requirements to obtain FDA approval. Upon funding, it is estimated that the products will be introduced in 24-36 months. Expect revenue > $60M 3-5 years after funding event.

Team

  • Default avatar
    Shirley Liu Clayton
    Founder

    Shirley Clayton, MBA, Stanford School of Business, was involved in early financing of the biotechnology industry at Genentech as VP and Treasurer in the early 1980s. She was CEO & President of Abmaxis (acquired by Merck &Co); CFO, Cybron, (acquired by GE Medical Systems); CFO, Orquest;
    President & CEO, Topometrix Corp. (acquired by Thermo Instruments); CFO, Cygnus; CFO, Protein Design Labs; President and Co-founder, Raven Biotechnologies

  • Default avatar
    Robert (Bob) Dunkle
    Strategy Officer

    Bob Dunkle, MBA, Strategic Business Development
    Bob has more than 20 years experience leading life sciences companies, including CEO and VP positions.  Bob serves as Entrepreneur-in-Residence at QB3 (UCSF incubator). 

  • Default avatar
    Nancy Mize
    Founder

    Nancy Mize, PhD, 10+ years managing Drug Development teams; Consultant, Pacific BioDevelopment;
    Director, Dept. Protein Bioinformatics, Hyseq; Preclinical development, Alza Corp;
    Inventor of 11 issued patents, including 2 issued stem cell factor patents. BS, UC Berkeley;
    PhD, UCSF; European Molecular Biology Laboratory (EMBL), and Genentech 

  • Default avatar
    Ellen Curtis
    Sales & Marketing

    Ellen Curtis, MBA, Stanford Graduate School of Business, Strategic Marketing and Product Planning. 15+ years in dermatology & skin repair including Vivus, Onset Dermatologics, Valeant, Dow, Connectics, OrthoNeutrogena, Sangstat

Advisors

  • Default avatar
    Glen Sato, Cooley
    Lawyer
    Unconfirmed
    Default avatar
    Kathleen Chao, CPA, C. G. Uhlenberg LLP
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Linda Avey, Co-founder of www.23andMe.com
    Unconfirmed